{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:11:14Z","timestamp":1792782674991,"version":"4.5.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82272953"],"award-info":[{"award-number":["82272953"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China","award":["82272951"],"award-info":[{"award-number":["82272951"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Key Research and Development Program of China","award":["2023YFC2508500"],"award-info":[{"award-number":["2023YFC2508500"]}]},{"name":"Innovation\u00a0Project\u00a0for\u00a0Medical and\u00a0Health\u00a0Sciences\u00a0and\u00a0Technology\u00a0of\u00a0Chinese\u00a0Academy\u00a0of\u00a0Medical\u00a0Sciences","award":["2024-I2M-TS-005"],"award-info":[{"award-number":["2024-I2M-TS-005"]}],"id":[{"id":"https:\/\/ror.org\/02drdmm93","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2025-LYZX-C-A03"],"award-info":[{"award-number":["2025-LYZX-C-A03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-026-04481-1","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:45:26Z","timestamp":1783331126000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety and feasibility of 5T4 antibody-coupled allogeneic NK cell therapy for solid tumors: a first-in-human phase 1 trial"],"prefix":"10.1007","volume":"75","author":[{"given":"Liangjie","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiwen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwei","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinduo","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3945-2536","authenticated-orcid":false,"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"issue":"1","key":"4481_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03437-0","volume":"20","author":"J Chu","year":"2022","unstructured":"Chu J, Gao F, Yan M et al (2022) Natural killer cells: a promising immunotherapy for cancer. J Transl Med 20(1):240. https:\/\/doi.org\/10.1186\/s12967-022-03437-0","journal-title":"J Transl Med"},{"issue":"1","key":"4481_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-025-00633-8","volume":"14","author":"LV J\u00f8rgensen","year":"2025","unstructured":"J\u00f8rgensen LV, Christensen EB, Barnkob MB et al (2025) The clinical landscape of CAR NK cells. Exp Hematol Oncol 14(1):46","journal-title":"Exp Hematol Oncol"},{"issue":"4","key":"4481_CR3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/abt\/tbaf019","volume":"8","author":"Y Yu","year":"2025","unstructured":"Yu Y, Ho M (2025) CAR NK cell therapy for solid tumors: potential and challenges. Antibody Ther 8(4):275\u2013289","journal-title":"Antibody Ther"},{"issue":"11","key":"4481_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-025-04196-9","volume":"74","author":"D Wang","year":"2025","unstructured":"Wang D, Li B, Shen G et al (2025) NKG2D CAR-NK adoptive cellular immunotherapy combined with or without PD-1 blockade in the treatment of patients with metastatic colorectal cancer: an exploratory study. Cancer Immunol Immunother 74(11):341","journal-title":"Cancer Immunol Immunother"},{"key":"4481_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2025.104972","volume":"216","author":"IJ Tuhin","year":"2025","unstructured":"Tuhin IJ, Zhu HJ, Monty MA et al (2025) From innate power to intelligent design: the evolution of NK cell-based cancer immunotherapy. Crit Rev Oncol Hematol 216:104972. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104972","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"4481_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1053\/j.seminhematol.2020.10.003","volume":"57","author":"I Terr\u00e9n","year":"2020","unstructured":"Terr\u00e9n I, Orrantia A, Vitall\u00e9 J et al (2020) Modulating NK cell metabolism for cancer immunotherapy. Semin Hematol 57(4):213\u2013224. https:\/\/doi.org\/10.1053\/j.seminhematol.2020.10.003","journal-title":"Semin Hematol"},{"key":"4481_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00368","volume":"6","author":"W Wang","year":"2015","unstructured":"Wang W, Erbe AK, Hank JA (2015) NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy. Front Immunol 6:368. https:\/\/doi.org\/10.3389\/fimmu.2015.00368","journal-title":"Front Immunol"},{"issue":"4","key":"4481_CR8","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00262-016-1917-3","volume":"66","author":"PL Stern","year":"2017","unstructured":"Stern PL, Harrop R (2017) 5T4 oncofoetal antigen: an attractive target for immune intervention in cancer. Cancer Immunol Immunother 66(4):415\u2013426. https:\/\/doi.org\/10.1007\/s00262-016-1917-3","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"4481_CR9","first-page":"610","volume":"8","author":"R Wang","year":"2018","unstructured":"Wang R, Lai Q, Tang L et al (2018) A novel 5T4-targeting antibody-drug conjugate H6-DM4 exhibits potent therapeutic efficacy in gastrointestinal tumor xenograft models. Am J Cancer Res 8(4):610\u2013623","journal-title":"Am J Cancer Res"},{"issue":"1","key":"4481_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1182\/asheducation-2016.1.106","volume":"2016","author":"RS Mehta","year":"2016","unstructured":"Mehta RS, Rezvani K (2016) Can we make a better match or mismatch with KIR genotyping? Hematol Am Soc Hematol Educ Program 2016(1):106\u2013118. https:\/\/doi.org\/10.1182\/asheducation-2016.1.106","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"2","key":"4481_CR11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.immuni.2006.06.013","volume":"25","author":"N Anfossi","year":"2006","unstructured":"Anfossi N, Andr\u00e9 P, Guia S et al (2006) Human NK cell education by inhibitory receptors for MHC class I. Immunity 25(2):331\u2013342. https:\/\/doi.org\/10.1016\/j.immuni.2006.06.013","journal-title":"Immunity"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-026-04481-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04481-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04481-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:14:09Z","timestamp":1790637249000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-026-04481-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":11,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["4481"],"URL":"https:\/\/doi.org\/10.1007\/s00262-026-04481-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9597110\/v1","asserted-by":"object"}]},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"3 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This FIH study was performed in accordance with the Declaration of Helsinki and was approved by the Ethics Committee and Institutional Review Boards of National Cancer Center\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (approvals No. 2023LP00207\/2023LP00208 and updated approvals No. 2024LB00345\/2024LB00346).","order":2,"name":"Ethics","label":"Ethics approval statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"239"}}